CYP2C9 antibody
Principal name
CYP2C9 antibody
Alternative names for CYP2C9 antibody
Cytochrome P450 2C9, CYP2C10, CYPIIC9, Cytochrome P450 PB-1, Cytochrome P450 MP-4/MP-8, (R)-limonene 6-monooxygenase, S-mephenytoin 4-hydroxylase
SwissProt ID
P11712 (Human)
Gene ID
1559 (CYP2C9)
Ncbi ID
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Functional assay (FN), Western blot / Immunoblot (WB), Paraffin Sections (P), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Enzyme Immunoassay (E)
Background of CYP2C9 antibody
CYP2C9 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that CYP2C9 gene is polymorphic.This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
General readings
Mohammed (er) Br. J. Pharmacol. (2008) In press

















- Quick-Filters:
- Highly Validated (2)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA503796 | CYP2C9 antibody |
||||||
| CYP2C9 (Cytochrome P450 2C9) mouse monoclonal antibody, clone OTI1D7 (formerly 1D7) | |||||||
![]() |
Mouse | IgG1 | OTI1D7 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
+4 additional images |
Highly validated antibody! |
||||||
| TA503816 | CYP2C9 antibody |
||||||
| CYP2C9 (Cytochrome P450 2C9) mouse monoclonal antibody, clone OTI2C8 (formerly 2C8) | |||||||
![]() |
Mouse | IgG1 | OTI2C8 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+3 additional images |
Highly validated antibody! |
||||||
| TA349844 | CYP2C9 antibody |
||||||
| Rabbit Polyclonal Anti-CYP2C9 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA503776 | CYP2C9 antibody |
||||||
| CYP2C9 (Cytochrome P450 2C9) mouse monoclonal antibody, clone OTI3D2 (formerly 3D2) | |||||||
![]() |
Mouse | IgG2a | OTI3D2 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| AP14722PU-N | CYP2C9 (N-term) antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| AP14731PU-N | CYP2C9 antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP320997 | CYP2C9 |
||||
| Recombinant protein of human cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||



+4 additional images





